Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 8959687, 14 pages
https://doi.org/10.1155/2017/8959687
Research Article

Activation of Peptidylarginine Deiminase in the Salivary Glands of Balb/c Mice Drives the Citrullination of Ro and La Ribonucleoproteins

1Department of Immunology, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, Guadalupe, ZAC, Mexico
2Pharmacology PhD Program, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara, JAL, Mexico

Correspondence should be addressed to Rafael Herrera-Esparza

Received 11 May 2017; Accepted 7 August 2017; Published 26 November 2017

Academic Editor: Douglas C. Hooper

Copyright © 2017 Mayra Rodríguez-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Eggleton, R. Haigh, and P. G. Winyard, “Consequence of neo-antigenicity of the ‘altered self’,” Rheumatology, vol. 47, no. 5, pp. 567–571, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Guerrin, A. Ishigami, M. Méchin et al., “cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I,” Biochemical Journal, vol. 370, no. 1, pp. 167–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Litt, Y. Qiu, and S. Huang, “Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation,” Bioscience Reports, vol. 29, no. 2, pp. 131–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. D. Morgan, F. Santos, K. Green, W. Dean, and W. Reik, “Epigenetic reprogramming in mammals,” Human Molecular Genetics, vol. 14, Supplement 1, pp. R47–R58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Arita, T. Shimizu, H. Hashimoto, Y. Hidaka, M. Yamada, and M. Sato, “Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 14, pp. 5291–5296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Coudane, M. C. Mechin, A. Huchenq et al., “Deimination and expression of peptidylarginine deiminases during cutaneous wound healing in mice,” European Journal of Dermatology, vol. 21, no. 3, pp. 376–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Wang and Y. Wang, “Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis,” Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, vol. 1829, no. 10, pp. 1126–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Nocturne and X. Mariette, “Advances in understanding the pathogenesis of primary Sjögren’s syndrome,” Nature Reviews Rheumatology, vol. 9, no. 9, pp. 544–556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Gottenberg, S. Mignot, P. Nicaise-Rolland et al., “Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome,” Annals of the Rheumatic Diseases, vol. 64, no. 1, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Herrera-Esparza, M. Rodríguez-Rodríguez, M. E. Pérez-Pérez et al., “Posttranslational protein modification in the salivary glands of Sjögren’s syndrome patients,” Autoimmune Diseases, vol. 2013, Article ID 548064, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Chen, D. W. Taylor, J. E. Galan, H. W. Wang, and S. L. Wolin, “An RNA degradation machine sculpted by Ro autoantigen and noncoding RNA,” Cell, vol. 153, no. 1, pp. 166–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Liang, K. Xiong, K. E. Szulwach et al., “Sjögren syndrome antigen B (SSB)/La promotes global microRNA expression by binding microRNA precursors through stem-loop recognition,” The Journal of Biological Chemistry, vol. 288, no. 1, pp. 723–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Henriksson, “Presymptomatic autoantibodies in Sjögren’s syndrome: what significance do they hold for the clinic?” Expert Review of Clinical Immunology, vol. 10, no. 7, pp. 815–817, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Miglio, E. Veglia, and R. Fantozzi, “Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells,” International Immunopharmacology, vol. 28, no. 1, pp. 215–219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Hecker, M. Küllmar, S. Wilker et al., “Phosphocholine-modified macromolecules and canonical nicotinic agonists inhibit ATP-induced IL-1β release,” The Journal of Immunology, vol. 195, no. 5, pp. 2325–2334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Cunningham, E. M. Corr, D. J. Cox, and A. Dunne, “Investigating inflammasome activation under conditions of cellular stress and injury,” Methods in Molecular Biology, vol. 1292, pp. 105–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Bizzaro, E. Tonutti, R. Tozzoli, and D. Villalta, “Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins,” Clinical Chemistry, vol. 53, no. 8, pp. 1527–1533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. H. Esparza, T. Swaak, L. Aarden, and R. Smeenk, “Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal,” Journal of Rheumatology, vol. 12, no. 6, pp. 1109–1117, 1985. View at Google Scholar
  19. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar
  20. S. Avrameas and T. Ternynck, “Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration,” Immunochemistry, vol. 8, no. 12, pp. 1175–1179, 1971. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Bollain-Y-Goytia, L. Mendoza‐Salazar, M. Romo‐Flores et al., “The presence of citrulline in salivary glands is evidence that nitric oxide is mediator of inflammation in Sjögren acinar epithelia,” International Journal of Rheumatic Diseases, vol. 11, no. 3, pp. 263–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Arandjelovic, K. R. McKenney, S. S. Leming, and K. A. Mowen, “ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor,” The Journal of Immunology, vol. 189, no. 8, pp. 4112–4122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. F. Spurlock 3rd., J. T. Tossberg, Y. Guo, S. Sriram, P. S. Crooke 3rd., and T. M. Aune, “Defective structural RNA processing in relapsing-remitting multiple sclerosis,” Genome Biology, vol. 16, p. 58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. E. R. Vossenaar, T. R. Radstake, A. van der Heijden et al., “Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages,” Annals of the Rheumatic Diseases, vol. 63, no. 4, pp. 373–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Jain, A. Nijhawan, A. K. Tyagi, and J. P. Khurana, “Validation of housekeeping genes as internal control for studying gene expression in rice by quantitative real-time PCR,” Biochemical and Biophysical Research Communications, vol. 345, no. 2, pp. 646–651, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Towbin, T. Staehelin, and J. Gordon, “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 9, pp. 4350–4354, 1979. View at Publisher · View at Google Scholar
  28. D. Damgaard, L. Senolt, M. F. Nielsen, G. J. Pruijn, and D. H. Nielsen, “Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen,” Arthritis Research & Therapy, vol. 16, no. 6, p. 498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. van Beers, A. J. Zendman, R. Raijmakers, J. Stammen-Vogelzangs, and G. J. Pruijn, “Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice,” Biochimie, vol. 95, no. 2, pp. 299–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Koziel, D. Bryzek, A. Sroka et al., “Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis,” The Journal of Immunology, vol. 192, no. 11, pp. 5363–5372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Ferrari-Lacraz, M. Sebbag, R. Chicheportiche, C. Foulquier, G. Serre, and J. M. Dayer, “Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes,” European Cytokine Network, vol. 23, no. 2, pp. 36–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Neeli, S. N. Khan, and M. Radic, “Histone deimination as a response to inflammatory stimuli in neutrophils,” The Journal of Immunology, vol. 180, no. 3, pp. 1895–1902, 2008. View at Publisher · View at Google Scholar
  33. H. J. Lee, M. Joo, R. Abdolrasulnia et al., “Peptidylarginine deiminase 2 suppresses inhibitory κB kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages,” The Journal of Biological Chemistry, vol. 285, no. 51, pp. 39655–39662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Abdullah, E. Farmer, L. Spargo, R. Logan, and N. Gully, “Porphyromonas gingivalis peptidylarginine deiminase substrate specificity,” Anaerobe, vol. 23, pp. 102–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Assohou-Luty, R. Raijmakers, W. E. Benckhuijsen et al., “The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities,” Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, vol. 1844, no. 4, pp. 829–836, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. H. H. Chang, N. Dwivedi, A. P. Nicholas, and I. Ho, “The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis,” Arthritis & Rheumatology, vol. 67, no. 9, pp. 2323–2334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Reyes-Castillo, C. A. Palafox-Sánchez, I. Parra-Rojas et al., “Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features,” Clinical & Experimental Immunology, vol. 182, no. 2, pp. 119–131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. A. G. Terzoglou, J. G. Routsias, H. M. Moutsopoulos, and A. G. Tzioufas, “Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding,” Clinical & Experimental Immunology, vol. 146, no. 1, pp. 60–65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. A. Stea, J. G. Routsias, M. Samiotaki et al., “Analysis of parotid glands of primary Sjögren’s syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets,” Clinical & Experimental Immunology, vol. 147, no. 1, pp. 81–89, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. E. R. Vossenaar, T. J. Smeets, M. C. Kraan, J. M. Raats, W. J. van Venrooij, and P. P. Tak, “The presence of citrullinated proteins is not specific for rheumatoid synovial tissue,” Arthritis & Rheumatology, vol. 50, no. 11, pp. 3485–3494, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. P. R. Vajjhala, A. Lu, D. L. Brown et al., “The inflammasome adaptor ASC induces procaspase-8 death effector domain filaments,” The Journal of Biological Chemistry, vol. 290, no. 49, pp. 29217–29230, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Stammler, T. Eigenbrod, S. Menz et al., “Inhibition of histone deacetylases permits lipopolysaccharide-mediated secretion of bioactive IL-1β via a caspase-1-independent mechanism,” The Journal of Immunology, vol. 195, no. 11, pp. 5241–5231, 2015. View at Publisher · View at Google Scholar · View at Scopus